A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: BIOLOGICAL: KN046|DRUG: Nab-paclitaxel
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd